Anjan Gupta is a Cardiology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 108 publications with 2,671 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6847 N Chestnut St Ste 100
Ravenna, OH 442663929
Telephone
330-297-6110Provider last certified this registry record 22 Dec 2020.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Penumbra, Inc.Program year20255 payments
- PFIZER INC.Program year202522 payments
- Novartis Pharmaceuticals CorporationProgram year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.9%Beta blocker20.2%Metoprolol Tartrate34%Carvedilol33%Metoprolol Succinate28%Sotalol2%Atenolol2%Bisoprolol Fumarate1%Part D<11 patientsStatin14.9%Atorvastatin Calcium69%Rosuvastatin Calcium16%Pravastatin Sodium10%Simvastatin5%Part D≥231 patients+ 16 more classes in this area
Blood & clotting
20.3%Factor Xa inhibitor10%Eliquis86%Xarelto14%Part D≥154 patientsP2Y12 inhibitor7.3%Clopidogrel69%Brilinta20%Prasugrel Hcl11%Part D≥122 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.2%SGLT2 inhibitor1.3%Jardiance78%Farxiga22%Part D<11 patientsProton pump inhibitor1%Pantoprazole Sodium100%Part D≥20 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prognostic Value of Pulmonary Artery Oxygen Saturation in Pulmonary Embolism Requiring Endovascular Intervention
The American Journal of Cardiology
2023 - Routine Use of the “Penumbra” Thrombectomy Device in Myocardial Infarction: A Real-World Experience—ROPUST Study
Journal of Interventional Cardiology
2022 - <scp>RVX</scp> 208: A novel <scp>BET</scp> protein inhibitor, role as an inducer of apo A‐I/<scp>HDL</scp> and beyond
Cardiovascular Therapeutics
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”